Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

Seton Pharmaceuticals, LLC and Senores Pharmaceuticals, Inc. launch Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/325 mg/40 mg in the U.S. market
  • USA - English


News provided by

Senores Pharmaceuticals Inc.

17 Mar, 2022, 17:24 IST

Share this article

Share toX

Share this article

Share toX

WALL, S.D. and ATLANTA and AHMEDABAD, India, March 17, 2022 /PRNewswire/ --  Seton Pharmaceuticals, LLC and Senores Pharmaceuticals, Inc. today announced the launch of Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/325 mg/40 mg, a therapeutic equivalent of the reference listed drug Butalbital, Acetaminophen, and Caffeine capsules of Mayne Pharma, Inc. in the U.S. market. The product will be distributed by Seton Pharmaceuticals, LLC.

Butalbital, Acetaminophen and Caffeine Capsules are indicated for the relief of the symptom complex of tension (or muscle contraction) headache.

Continue Reading
Seton Pharmaceuticals, LLC and Senores Pharmaceuticals, Inc. launch
 Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/325 mg/40 mg 
in the U.S. market
Seton Pharmaceuticals, LLC and Senores Pharmaceuticals, Inc. launch Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/325 mg/40 mg in the U.S. market

"We are pleased to collaborate with Seton Pharmaceuticals for the commercial launch of Butalbital, Acetaminophen and Caffeine Capsules in the U.S. market" stated Dhananjay Barot, Director, Senores Pharmaceuticals, Inc. "Our unfaltering adherence towards the pharmaceutical industry makes us a major supplier for this product" stated Swapnil Shah, Managing Director, Senores Group.

"Seton is proud to partner with Senores on the launch of Butalbital, Acetaminophen and Caffeine Capsules" stated Christopher McCarthy, Executive Vice President of Seton Pharmaceuticals, LLC. "This continues our commitment to providing affordable medicines to the consumer through quality manufacturing partnerships."

U.S. annual market size for Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/325 mg/40 mg was approximately US$29.18 million (Symphony, Dec 2021).

About Seton Pharmaceuticals, LLC

Seton Pharmaceuticals, LLC was established in 2007 in Wall Township, New Jersey. Focusing on FDA approved generic pharmaceuticals, Seton partners with developers and manufacturers to launch ANDA products under the Seton label. With a strong emphasis on product & financial management and supplier & customer service, Seton delivers unparalleled product quality.

About Senores Pharmaceuticals, Inc. 

Senores Pharmaceuticals, based in Atlanta, Georgia is one of the fastest-growing pharmaceutical companies in the U.S. market. Currently, the company has more than 15 products commercially launched or filed with the USFDA.

Seton Pharmaceuticals, LLC
1967 Highway 34
Wall Township New Jersey 07719
800-510-3401
www.setonpharmaceuticals.com

Senores Pharmaceuticals, Inc. 
Atlanta,
Georgia
www.senorespharma.com 

Photo: https://mma.prnewswire.com/media/1768571/Senores_Pharma__Seton_Pharma.jpg

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.